Digital PCR for MRD detection of myeloma
- Publication Type:
- Conference Proceeding
- Clinical Lymphoma, Myeloma & Leukemia, 2015, 15 (Supplement 3), pp. E95 - E95 (1)
- Issue Date:
Copyright Clearance Process
- Recently Added
- In Progress
- Closed Access
This item is closed access and not available.
A pilot study was performed to investigate the use of digital PCR (dPCR) to detect minimal residual disease (MRD) in patients with multiple myeloma. dPCR allows greater quantitative specificity in PCR reactions by performing multiple, minute PCR reactions on individual DNA templates.
Please use this identifier to cite or link to this item: